Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 6/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6932180 | 0.83 | SIGMAR1 (0.47) | HPGDMEN1KMT2AALDH1A1TSHR | |
| SCHEMBL24528365 | 0.83 | RAB9A (0.53) | HPGDMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL13165368 | 0.83 | RAB9A (0.53) | HPGDMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL5774618 | 0.81 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL5774614 | 0.81 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL11789537 | 0.79 | L3MBTL1 (0.46) | HPGDMEN1KMT2AALDH1A1AKR1C3 | |
| SCHEMBL11789535 | 0.79 | L3MBTL1 (0.46) | HPGDMEN1KMT2AALDH1A1AKR1C3 | |
| SCHEMBL22596690 | 0.79 | ALDH1A1 (0.44) | HPGDMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL3885423 | 0.78 | HPGD (0.54) | HPGDMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL5775659 | 0.78 | SMN1; SMN2 (0.53) | HPGDALDH1A1KDM4ETSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150011698-A1 | METHOD FOR PRODUCING CONJUGATED DIENE-BASED POLYMER, AND METHOD FOR PRODUCING CONJUGATED DIENE-BASED POLYMER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20150005440-A1 | CONJUGATED DIENE POLYMER PRODUCTION METHOD, AND CONJUGATED DIENE POLYMER COMPOSITION PRODUCTION METHOD | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-01-01 | — | — | US | disclosed |
| US-8299179-B2 | Conjugated diene-based polymer, conjugated diene-based polymer composition, and process for producing conjugated diene-based polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20120041136-A1 | CONJUGATED DIENE-BASED POLYMER, CONJUGATED DIENE-BASED POLYMER COMPOSITION, AND PROCESS FOR PRODUCING CONJUGATED DIENE-BASED POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20050182113-A1 | Method for preparing diaryl-substituted isoxazole compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-08-18 | — | — | US | disclosed |
| EP-1550658-A1 | Method for preparing 3,4-diphenyl-substituted isoxazole compounds | Dr. Reddy's Laboratories Ltd. (IN) | 2005-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182113-A1 | Method for preparing diaryl-substituted isoxazole compounds | CYP2C9, CYP3A7, CYP3A5 | HPGD 52/4885MEN1 1233/4885KMT2A 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.